A recent guideline downgrade of coronary artery bypass graft surgery relative to medical therapy is unjustified and not based on assessment of all evidence to date, contends one of our cardiothoracic surgeons.
Read MoreAdjustable Soft Robotic Sleeve Mimics Complex Hemodynamics of Aortic Stenosis
A novel soft robotic device designed to fit around the ascending aorta promises to enable high-fidelity simulation of the hemodynamics and biomechanics of aortic stenosis and congenital valve disease.
Ultra-Hybrid Repair of Thoracoabdominal Aortic Aneurysm: A Good Option for Pan-Aorta Involvement
Treating extensive aortic aneurysm disease with descending thoracic aorta stent grafting followed later by distal open completion can yield outcomes comparable to those with open repair, a large series shows.
Translating Genomics to Therapeutics for Atrial Fibrillation
A multifront Cleveland Clinic research project aims to use $14 million in NIH funding to identify mechanisms and targets underlying AF that may lead to personalized therapies.
Analysis Shows No Long-Term Mortality Difference in CABG With Radial Artery Vs. Saphenous Vein Grafts
Findings from a major multicenter study suggest that it’s premature to endorse the radial artery as the second conduit of choice.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Statins Reduce Circulating TMAO, Suggesting Another Way They Curb Cardiovascular Risk
A new study suggests that plasma levels of this gut microbial metabolite might help further stratify cardiovascular risk when characterizing patients’ response to statin therapy.
Mavacamten’s Effects Against Obstructive Hypertrophic Cardiomyopathy Persist Through 32 Weeks in VALOR-HCM
Reductions in guideline eligibility for septal reduction therapy were sustained in patients initially randomized to mavacamten and were swiftly achieved in patients crossed over from placebo to active drug.
Dietary Supplements Don’t Stack Up to Low-Dose Statin Therapy for LDL-C Reduction
Despite marketing claims, none of six dietary supplements commonly used for lipid lowering significantly reduced LDL cholesterol versus placebo adults with elevated atherosclerotic risk, a new study finds.
The Value of an Observational Visit to Cleveland Clinic’s Heart, Vascular & Thoracic Institute for an Alliance Hospital
A team from Parkview Heart Institute recently made a site visit to gain insights for expanding their vein clinic and enhancing operations across their vascular program. Here’s a case study of what they came away with.
How Autoimmune Disorders Impact Myocardial Infarction Treatment and Long-Term Outcomes
Underlying rheumatic autoimmune disease was associated with reduced use of coronary interventions for MI and a 15% increase in all-cause mortality in the two years after infarction, a large analysis finds.
A Close-Up Look at Presentation of Transthyretin Amyloid Cardiomyopathy With Impaired LV Function
Nearly one-half of patients with ATTR-CM present with impaired left ventricular function, finds a large study in a racially and genetically diverse cohort.